239 related articles for article (PubMed ID: 15913489)
1. Is hypertension a prothrombotic state?
Varughese GI; Lip GY
Curr Hypertens Rep; 2005 Jun; 7(3):168-73. PubMed ID: 15913489
[TBL] [Abstract][Full Text] [Related]
2. The prothrombotic state in hypertension and the effects of antihypertensive treatment.
Nadar S; Lip GY
Curr Pharm Des; 2003; 9(21):1715-32. PubMed ID: 12871204
[TBL] [Abstract][Full Text] [Related]
3. Hypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapy.
Kakar P; Lip GY
Expert Rev Cardiovasc Ther; 2007 May; 5(3):441-50. PubMed ID: 17489669
[TBL] [Abstract][Full Text] [Related]
4. Does hypertension confer a hypercoagulable state?
Lip GY; Li-Saw-Hee FL
J Hypertens; 1998 Jul; 16(7):913-6. PubMed ID: 9794730
[TBL] [Abstract][Full Text] [Related]
5. The role of renin-angiotensin system in prothrombotic state in essential hypertension.
Remková A; Remko M
Physiol Res; 2010; 59(1):13-23. PubMed ID: 19249905
[TBL] [Abstract][Full Text] [Related]
6. Hypertension and the prothrombotic state.
Lip GY
J Hum Hypertens; 2000; 14(10-11):687-90. PubMed ID: 11095159
[TBL] [Abstract][Full Text] [Related]
7. Vascular smooth muscle cells are responsible for a prothrombotic phenotype of spontaneously hypertensive rat arteries.
Ait Aissa K; Lagrange J; Mohamadi A; Louis H; Houppert B; Challande P; Wahl D; Lacolley P; Regnault V
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):930-7. PubMed ID: 25722431
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological modulation of platelet function in hypertension.
Blann AD; Nadar S; Lip GY
Hypertension; 2003 Jul; 42(1):1-7. PubMed ID: 12782643
[TBL] [Abstract][Full Text] [Related]
9. Novel concepts of statin therapy for cardiovascular risk reduction in hypertension.
Varughese GI; Patel JV; Lip GY; Varma C
Curr Pharm Des; 2006; 12(13):1593-609. PubMed ID: 16729872
[TBL] [Abstract][Full Text] [Related]
10. Should patients with hypertension receive antithrombotic therapy?
Lip GY; Edmunds E; Beevers DG
J Intern Med; 2001 Mar; 249(3):205-14. PubMed ID: 11285041
[TBL] [Abstract][Full Text] [Related]
11. Target organ damage in hypertension: pathophysiology and implications for drug therapy.
Nadar SK; Tayebjee MH; Messerli F; Lip GY
Curr Pharm Des; 2006; 12(13):1581-92. PubMed ID: 16729871
[TBL] [Abstract][Full Text] [Related]
12. Coagulation and thrombosis in cardiovascular disease: plausible contributions of infectious agents.
Herzberg MC
Ann Periodontol; 2001 Dec; 6(1):16-9. PubMed ID: 11887459
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic and prothrombotic activities of the vascular endothelium.
Sagripanti A; Carpi A
Biomed Pharmacother; 2000 Mar; 54(2):107-11. PubMed ID: 10759296
[TBL] [Abstract][Full Text] [Related]
14. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Devereux RB; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
[TBL] [Abstract][Full Text] [Related]
15. [Hypertension and vascular diseases: molecular and cellular mechanisms].
Lüscher TF
Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
[TBL] [Abstract][Full Text] [Related]
16. Impact of the therapy by renin-angiotensin system targeting antihypertensive agents perindopril versus telmisartan on prothrombotic state in essential hypertension.
Remková A; Kratochvíl'ová H; Durina J
J Hum Hypertens; 2008 May; 22(5):338-45. PubMed ID: 18305548
[TBL] [Abstract][Full Text] [Related]
17. Pathobiology of pulmonary hypertension. The role of platelets and thrombosis.
Herve P; Humbert M; Sitbon O; Parent F; Nunes H; Legal C; Garcia G; Simonneau G
Clin Chest Med; 2001 Sep; 22(3):451-8. PubMed ID: 11590840
[TBL] [Abstract][Full Text] [Related]
18. Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
Lip GY; Gibbs CR
J Am Coll Cardiol; 1999 Apr; 33(5):1424-6. PubMed ID: 10193748
[TBL] [Abstract][Full Text] [Related]
19. What "drives" the link between the renin-angiotensin-aldosterone system and the prothrombotic state in hypertension?
Tay KH; Lip GY
Am J Hypertens; 2008 Dec; 21(12):1278-9. PubMed ID: 19020509
[No Abstract] [Full Text] [Related]
20. Review of the molecular pharmacology of Losartan and its possible relevance to stroke prevention in patients with hypertension.
Díez J
Clin Ther; 2006 Jun; 28(6):832-48. PubMed ID: 16860167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
